- $88.40m
- -$4.45m
- $0.86m
Brief: Rallybio Corp Discontinues Rlyb212 Program For Prevention Of Fnait
Brief: Rallybio Says Entered Amendment To Certain Sales Agreement
Brief: Rallybio Q4 Net Income USD -11.044 Million
Brief: Rallybio Announces Initiation Of Dosing In RLYB212 Phase 2 Clinical Trial
Brief: Rallybio To Provide Update On Rlyb116 Program
Brief: Rallybio Announces Initiation Of Phase 2 Clinical Trial Of RLYB212
Brief: Rallybio Q3 Net Income USD -11.466 Million
Brief: Rallybio Announces Approval Of Clinical Trial Applications For Phase 2 Trial Of RLYB212 In Pregnant Women At Higher Risk Of Alloimmunization And FNAIT
Brief: Rallybio Announces Publication Of Rlyb212 Phase 1 Proof-Of-Concept Study Results
Brief: Rallybio Q2 Net Income USD -16.236 Million
Brief: Rallybio Says Martin Mackay To Resign As Executive Chairman
Brief: Rallybio Announces Results Demonstrating FNAIT Risk Across Racially And Ethnically Diverse Populations
U.S. RESEARCH ROUNDUP- Altus Power, Jack in the Box, Home Depot
U.S. RESEARCH ROUNDUP- Altus Power, Jack in the Box, Home Depot
Brief: Rallybio Files Prospectus Related To Disposition Of Up To 3.6 Mln Shares Of Common Stock By Selling Stockholder
Brief: Rallybio Q1 Net Income USD -19.029 Million
U.S. STOCKS ON THE MOVE-Constellation Brands, Nike, Rocket Lab
U.S. STOCKS ON THE MOVE-DoorDash, Devon Energy, Arvinas
U.S. STOCKS ON THE MOVE-Rallybio, Alpine Immune, Marcus